Vycor Medical Statistics
Total Valuation
Vycor Medical has a market cap or net worth of 2.30 million. The enterprise value is 3.11 million.
| Market Cap | 2.30M |
| Enterprise Value | 3.11M |
Important Dates
The last earnings date was Tuesday, May 26, 2026.
| Earnings Date | May 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Vycor Medical has 33.37 million shares outstanding. The number of shares has increased by 0.91% in one year.
| Current Share Class | 33.37M |
| Shares Outstanding | 33.37M |
| Shares Change (YoY) | +0.91% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.15% |
| Owned by Institutions (%) | n/a |
| Float | 12.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.22 |
| PB Ratio | -0.54 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 21.39 |
| P/OCF Ratio | 20.40 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.12, with an EV/FCF ratio of 28.89.
| EV / Earnings | -9.20 |
| EV / Sales | 1.65 |
| EV / EBITDA | 13.12 |
| EV / EBIT | 33.62 |
| EV / FCF | 28.89 |
Financial Position
The company has a current ratio of 0.13
| Current Ratio | 0.13 |
| Quick Ratio | 0.07 |
| Debt / Equity | n/a |
| Debt / EBITDA | 4.14 |
| Debt / FCF | 9.11 |
| Interest Coverage | 0.89 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 6.44% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -2.26% |
| Weighted Average Cost of Capital (WACC) | 3.44% |
| Revenue Per Employee | 269,366 |
| Profits Per Employee | -48,304 |
| Employee Count | 7 |
| Asset Turnover | 2.10 |
| Inventory Turnover | 1.72 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.26% in the last 52 weeks. The beta is -0.53, so Vycor Medical's price volatility has been lower than the market average.
| Beta (5Y) | -0.53 |
| 52-Week Price Change | -46.26% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | 0.10 |
| Relative Strength Index (RSI) | 38.08 |
| Average Volume (20 Days) | 23,446 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.51 |
Income Statement
In the last 12 months, Vycor Medical had revenue of 1.89 million and -338,125 in losses. Loss per share was -0.01.
| Revenue | 1.89M |
| Gross Profit | 1.58M |
| Operating Income | 92,514 |
| Pretax Income | -11,581 |
| Net Income | -338,125 |
| EBITDA | 155,215 |
| EBIT | 92,514 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 173,634 in cash and 980,812 in debt, with a net cash position of -807,178 or -0.02 per share.
| Cash & Cash Equivalents | 173,634 |
| Total Debt | 980,812 |
| Net Cash | -807,178 |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | -4.23M |
| Book Value Per Share | -0.13 |
| Working Capital | -4.30M |
Cash Flow
In the last 12 months, operating cash flow was 112,860 and capital expenditures -5,224, giving a free cash flow of 107,636.
| Operating Cash Flow | 112,860 |
| Capital Expenditures | -5,224 |
| Depreciation & Amortization | 62,701 |
| Net Borrowing | 1,968 |
| Free Cash Flow | 107,636 |
| FCF Per Share | 0.00 |
Margins
Gross margin is 83.67%, with operating and profit margins of 4.91% and -0.73%.
| Gross Margin | 83.67% |
| Operating Margin | 4.91% |
| Pretax Margin | -0.61% |
| Profit Margin | -0.73% |
| EBITDA Margin | 8.23% |
| EBIT Margin | 4.91% |
| FCF Margin | 5.71% |
Dividends & Yields
Vycor Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.91% |
| Shareholder Yield | -0.91% |
| Earnings Yield | -14.68% |
| FCF Yield | 4.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 15, 2013. It was a reverse split with a ratio of 0.0066666.
| Last Split Date | Jan 15, 2013 |
| Split Type | Reverse |
| Split Ratio | 0.0066666 |
Scores
Vycor Medical has an Altman Z-Score of -58.34 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -58.34 |
| Piotroski F-Score | 6 |